Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels

EGP increases steeply with glucagon doses between 25 and 175 µg at lower insulin infusion rates. However, high insulin infusion rates prevent these doses of glucagon from significantly increasing glucose output and may reduce glucagon effectiveness in preventing hypoglycemia when used in the artificial pancreas (Diabetes Care)